P

Inventor

DI FRANCESCO MARIA EMILIA

US34 patents
⚠️ This page may combine multiple inventors who share the name “DI FRANCESCO MARIA EMILIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV TEXAS

20 patents
US10344025B2Jul 9, 2019

GLS1 inhibitors for treating disease

UNIV TEXAS12 citations91
US9809588B2Nov 7, 2017

GLS1 inhibitors for treating disease

UNIV TEXAS15 citations91
US11370786B2Jun 28, 2022

GLS1 inhibitors for treating disease

UNIV TEXAS6 citations84
US10766892B2Sep 8, 2020

GLS1 inhibitors for treating disease

UNIV TEXAS9 citations83
US10421765B2Sep 24, 2019

Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

UNIV TEXAS7 citations82
US10392376B2Aug 27, 2019

Heterocyclic inhibitors of ATR kinase

UNIV TEXAS7 citations82
US11400108B2Aug 2, 2022

Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

UNIV TEXAS1 citations73
US10933078B2Mar 2, 2021

Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

UNIV TEXAS2 citations73
US10363248B2Jul 30, 2019

Salts of heterocyclic modulators of HIF activity for treatment of disease

UNIV TEXAS2 citations73
US11958849B2Apr 16, 2024

GLS1 inhibitors for treating disease

UNIV TEXAS2 citations72
US11001594B2May 11, 2021

Heterocyclic modulators of HIF activity for treatment of disease

UNIV TEXAS1 citations72
US10800769B2Oct 13, 2020

Heterocyclic inhibitors of ATR kinase

UNIV TEXAS2 citations71
US10800774B2Oct 13, 2020

Heterocyclic inhibitors of ATR kinase

UNIV TEXAS2 citations71
US10745420B2Aug 18, 2020

Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase

UNIV TEXAS2 citations71
US12036231B2Jul 16, 2024

Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling

UNIV TEXAS0 citations62
US10888554B2Jan 12, 2021

Salts of heterocyclic modulators of HIF activity for treatment of disease

UNIV TEXAS0 citations62
US11725008B2Aug 15, 2023

Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

UNIV TEXAS0 citations61
US11434233B2Sep 6, 2022

Heterocyclic inhibitors of ATR kinase

UNIV TEXAS0 citations61
US11028083B2Jun 8, 2021

Ethanediamine-heterocycle derivatives as inhibitors of protein arginine methyltransferases

UNIV TEXAS1 citations61
US10894052B2Jan 19, 2021

Heterocyclic inhibitors of ATR kinase

UNIV TEXAS1 citations61

ALTMAN MICHAEL D

4 patents

MERCK SHARP & DOHME

4 patents

DI FRANCESCO MARIA EMILIA

2 patents

BOARD OF REGENTS UNIV OF TEXAS SYSTEM

2 patents

HARPER STEVEN

1 patent

DESCHENES DENIS

1 patent